18F-FDG PET-CT in the evaluation of paraneoplastic syndromes: experience at a regional oncology centre.

ObjectivesParaneoplastic syndromes (PNS) are remote manifestations of malignancy unrelated to tumour invasion or metastases. They pose a diagnostic challenge because of diverse presentations. 18F-Fluorodeoxyglucose (18F-FDG) PET-CT is an emerging technique for the detection of malignancy; however, t